Category Archives: prescription drugs

A Must Read Book About the Players That Drove the Opiod Epidemic from the Get Go

Dream Land is an engaging read–well written and well researched.  Sam Quinones, author and journalist, traces the Opiod epidemic from the first distillation of Morphine from opium in 1804 to the present.  He even includes the Opium Wars between the … Continue reading

Posted in opiod epidemic, pharmaceutical companies, prescription drugs | Tagged , , , , , , , , , | Leave a comment

Drug Money: Companies Flipping Drugs for Profit and Costs of Cancer Care and Drug Company Political Contributions, Drug Coupons and Costly Diabetes Drugs

I don’t usually do this, but these four articles speak for themselves on drug costs and I am on my way to a conference. 1) Drug companies are selling their drugs to others after a patent expires and those companies … Continue reading

Posted in investors, medical bankruptcy, pharmaceutical companies, prescription drugs | Tagged , , , , , , , | Leave a comment

Pharmaceutical costs–what’s behind them

I have been recovering from my hip replacement surgery with a few post surgical complications from another ailment.  That said, I could not resist sharing this link from the Kaiser Family Foundation news service. They are a 501© 3 non-profit … Continue reading

Posted in consumer protection, pharmaceutical companies, prescription drugs, technology and pharmaceutical costs, Uncategorized | Tagged , , , , , , | Leave a comment

See How America’s Health Care Costs and Outcomes Compare to Others

I have been busy on a project and not blogging as frequently.  Given the discussions about health care in the election, however, I thought people would find this brief graphic video by the Kaiser Family Foundation of interest.  It shows … Continue reading

Posted in Affordable Care Act, Economy, Health Care Reform, health insurance, patient safety, policy and politics, politics, prescription drugs, public dialogue, quality of care, technology and pharmaceutical costs | Tagged , , , , , , , , , , , , , , , , , , | Leave a comment

Congress Tackles Drug Prices: Much Bipartisan Support; and Recent Trends in Drug Costs Here and What Other Countries Pay

Finally it looks like Congress might just re-visit Medicare Part D and let Medicare negotiate rates with drug companies.   See charts below: http://www.statnews.com/2015/12/01/stat-harvard-drug-prices-poll/  The VA and Medicaid can negotiate rates. Senate Special Committee on Aging holds drug costs hearing December … Continue reading

Posted in aging, Economy, media, Medicare, pharmaceutical companies, policy and politics, politics, prescription drugs, technology and pharmaceutical costs | Tagged , , , , , , , , , , , , , , , , , , , , , , , | Leave a comment

Drug Costs and Congress: Investments, Contributions and You

A scathing new article on Congress and its financial conflicts of interests with drug and device companies appears in STAT, a news firm specializing in health and science. It examines Senators and Representatives who have oversight of the FDA and … Continue reading

Posted in health insurance, medical bankruptcy, Medicare, pharmaceutical companies, policy and politics, prescription drugs, public dialogue, technology and pharmaceutical costs | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , | Leave a comment

Drug Clinical Trials, Comparative Effectiveness, and much more

In 2013, I ran a 2 column series on how pharmaceutical products are tested and evaluated before going on the market (see link below). In light of the current discussions about drug prices, here are some things you might be … Continue reading

Posted in business, consumer protection, pharmaceutical companies, prescription drugs | Tagged , , , , , , , , , , , , , , , , | Leave a comment